| RS2140115541 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2140117236 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS2140119519 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2140122536 |
DICER1
|
Health Risk |
Likely pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140122597 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS2140122641 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2140122670 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140122740 |
TMEM63C
|
Health Risk |
Pathogenic |
Spastic paraplegia 87, autosomal recessive |
| RS2140123124 |
DICER1
|
Health Risk |
Pathogenic |
— |
| RS2140123302 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140124358 |
DICER1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2140124458 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140125178 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140126563 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2140127010 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2140127042 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2140127157 |
GCH1
|
Health Risk |
Likely pathogenic |
Abnormal central motor function, Abnormal central motor function |
| RS2140127185 |
TMEM63C
|
Health Risk |
Pathogenic |
Spastic paraplegia 87, autosomal recessive |
| RS2140127251 |
GCH1
|
Health Risk |
Pathogenic |
— |
| RS2140127278 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2140127425 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS2140127551 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS2140127822 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, Dystonia 5 |
| RS2140128017 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2140128191 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2140129581 |
TRIP11
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IA |
| RS2140129677 |
TMEM63C
|
Health Risk |
Pathogenic |
Spastic paraplegia 87, autosomal recessive |
| RS2140130724 |
TMEM63C
|
Health Risk |
Pathogenic |
Spastic paraplegia 87, autosomal recessive |
| RS2140131376 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2140132816 |
NALCN
|
Health Risk |
Likely pathogenic |
Congenital contractures of the limbs and face, hypotonia |
| RS2140132909 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2140132954 |
NALCN
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2140138107 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2140138146 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2140138203 |
ATP11A
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS2140138808 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140138974 |
DICER1
|
Health Risk |
Likely pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140141345 |
RDH12
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Leber congenital amaurosis 13 |
| RS2140142183 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2140145138 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2140145142 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2140145266 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2140145502 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2140145565 |
PSEN1
|
Health Risk |
Pathogenic |
Alzheimer disease 3, Pick disease |
| RS2140145566 |
RDH12
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS2140145599 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Macular dystrophy, Leber congenital amaurosis 13 |
| RS2140150119 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140151036 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2140155252 |
TTLL5
|
Health Risk |
Likely pathogenic |
— |
| RS2140156819 |
NALCN
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2140159183 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2140159358 |
KIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS2140159368 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2140161227 |
KIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS2140161563 |
KIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS2140161617 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2140161850 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2140162237 |
POMT2
|
Health Risk |
Pathogenic |
— |
| RS2140162488 |
RDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 13, Retinitis pigmentosa |
| RS2140162541 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2140162576 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS2140162581 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2140162883 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2140163000 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS2140167500 |
KIF5A
|
Health Risk |
Pathogenic |
— |
| RS2140169285 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2140172189 |
KIF5A
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2140181246 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140183172 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2140184247 |
PPIB
|
Health Risk |
Likely pathogenic |
— |
| RS2140184412 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Spastic paraplegia |
| RS2140185342 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2140185372 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140185423 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140185428 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Abnormal central motor function, Abnormal central motor function |
| RS2140185555 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS2140185593 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2140188352 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2140188685 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140188825 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140188838 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS2140188891 |
SMAD3
|
Health Risk |
Likely pathogenic |
Isolated thoracic aortic aneurysm, Isolated thoracic aortic aneurysm |
| RS2140189193 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS2140192941 |
ZFYVE26
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS2140192948 |
ZFYVE26
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140193931 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140194241 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Abnormal central motor function, Abnormal central motor function |
| RS2140194701 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140199019 |
GABRB3
|
Health Risk |
Pathogenic |
— |
| RS2140199204 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140199396 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140199533 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140199559 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140199587 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2140200556 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140201228 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2140201330 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140201355 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140201554 |
PPFIBP1
|
Health Risk |
Pathogenic |
Microcephaly, Severe intellectual disability |
| RS2140201750 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |